NYLI WMC Value Investor Class (MSMIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
27.64
-0.61 (-2.16%)
Apr 21, 2025, 4:00 PM EDT
-1.64% (1Y)
Fund Assets | 1.13B |
Expense Ratio | 1.86% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 1.48 |
Dividend Yield | 5.08% |
Dividend Growth | 23.92% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 9, 2024 |
Previous Close | 28.25 |
YTD Return | -5.86% |
1-Year Return | 3.12% |
5-Year Return | 90.56% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 71 |
Inception Date | Feb 28, 2008 |
About MSMIX
The NYLI WMC Value Investor Class (MSMIX) seeks to earn income as a secondary objective. MSMIX normally invests at least 65% of its total assets in equity-type securities.
Category Large Value
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol MSMIX
Share Class Investor Class
Index Russell 1000 Value NR
Performance
MSMIX had a total return of 3.12% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.96%.
Top 10 Holdings
24.27% of assetsName | Symbol | Weight |
---|---|---|
JPMorgan Chase & Co. | JPM | 3.98% |
UnitedHealth Group Incorporated | UNH | 3.35% |
Johnson & Johnson | JNJ | 3.10% |
Cisco Systems, Inc. | CSCO | 2.47% |
Pfizer Inc. | PFE | 1.97% |
American International Group, Inc. | AIG | 1.97% |
Elevance Health, Inc. | ELV | 1.93% |
MetLife, Inc. | MET | 1.85% |
Gilead Sciences, Inc. | GILD | 1.84% |
Merck & Co., Inc. | MRK | 1.81% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 9, 2024 | $1.47654 | Dec 9, 2024 |
Dec 6, 2023 | $1.19155 | Dec 6, 2023 |
Dec 7, 2022 | $1.51496 | Dec 7, 2022 |
Dec 2, 2021 | $25.59318 | Dec 2, 2021 |
Dec 2, 2020 | $1.55032 | Dec 2, 2020 |
Dec 2, 2019 | $3.40408 | Dec 2, 2019 |